Blog

Proposed FY26 Budget Cuts Threaten Progress in Cancer Research and Patient Survival – ACS CAN

ACS CAN/LinkedIn

May 31, 2025, 18:43

Proposed FY26 Budget Cuts Threaten Progress in Cancer Research and Patient Survival – ACS CAN

American Cancer Society Cancer Action Network (ACS CAN) shared a post on LinkedIn:

“Today, the president released his final proposed budget for Fiscal Year 2026, which contains $4.531 billion for the National Cancer Institute (NCI). This represents a cut of almost $2.7 billion, or approximately 37.2%, from the current fiscal year.

Overall, the budget proposal slices 25.2% from the U.S. Department of Health and Human Services (HHS). This also includes a 40.4% cut to The National Institutes of Health (NIH) and a 53.3% cut to the Centers for Disease Control and Prevention (CDC).

For the past 50 years, every significant medical breakthrough, especially in the treatment of cancer, has been linked to sustained federal investment in research at NIH and NCI. This commitment has contributed to the remarkable statistic of over 18 million cancer survivors currently living in the U.S. today.

In addition, NCI-supported ClinicalTrials implemented between 1980 and 2020 were estimated to have added 14.2 million additional life-years to patients with cancer. Moving backwards in funding would not only stall scientific breakthroughs but also impact our ability to combat the rising incidence of cancer nationwide. Cuts have consequences, and those consequences are life-threatening for cancer patients who could be waiting for the next clinical trial or research breakthrough.

These proposed cuts will lead to more suffering and death from cancer, reversing course on the downward trend in cancer death rates. ACS CAN calls on the president to reverse course and protect the programs and services at HHS that have made our country a global leader in cancer research.”

Read the full statement.

More posts featuring ACS CAN.

ACS CAN American Cancer Society Cancer Action Network cancer HHS National Cancer Institute National Institutes of Health NCI NIH OncoDaily Oncology U.S. Department of Health and Human Services

15 Posts Not to Miss from the 1st Day of ASCO 2025

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group